Madison Partners Named to Newsweek’s America’s Top Financial Advisory Firms 2026
Fee-only fiduciary firm earns five-star rating with five-year asset growth more than three times the industry median, after independent evaluation of more than 16,000... Read more.
Pusan National University: Beyond Antibiotics–A Paradigm Shift Toward Bacteria-Control-Centric Therapies
Novel extracellular vesicle platform helps polymyxins kill multidrug-resistant gram-negative bacteria at lower and potentially safer doses BUSAN, South Korea, July... Read more.
Deliverect and SoundHound AI Partner to Turn Voice Into a Fully Automated Ordering Channel for Restaurants
The integration creates a seamless, automated path from a customer’s first voice interaction to kitchen fulfillment, across drive-thru, phone, kiosk, and in-car... Read more.
LightPath Technologies Signs Definitive Agreement to Divest China Operations
Divestiture to Complete Transition to Fully Western-Aligned Manufacturing Footprint, Reinforcing Position as a Trusted Optics and Imaging Solutions for Mission-Critical... Read more.
Canada invests in the Prince Edward Island-New Brunswick Interconnection Expansion Project
CHARLOTTETOWN, PE, July 23, 2026 /CNW/ — Canada’s economy and security depend on reliable, affordable electricity, and national electricity demand is... Read more.
Halozyme to Report Second Quarter 2026 Financial and Operating Results
SAN DIEGO, July 23, 2026 /PRNewswire/ — Halozyme Therapeutics, Inc. (Nasdaq: HALO) (“Halozyme”) today announced it will release its second quarter... Read more.
The Sky Is No Longer the Limit: Drones as a Service Adoption Reaches Critical Mass Projected to Exceed $250 Billion Growth
Drone-as-a-Service Is Transforming How Companies Inspect, Monitor, Map, and Manage Critical Assets Market News Updates News Commentary NEW YORK, July 23, 2026 /PRNewswire/... Read more.
LittleHorse Unveils Saddle Command Center, the Business-as-Code Platform for Solving Malorchestration Disorder with Agents, Microservices, and Events
Easy, Smart, Effective: Bridge the gap to successfully operationalize AI with Business-as-Code LAS VEGAS, July 23, 2026 /PRNewswire/ — LittleHorse delivered... Read more.
TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma
Investigational MonumenTAL-6 trial is the first and only Phase 3 study of a dual antigen, BCMA and GPRC5D targeting regimen in relapsed/refractory multiple myeloma... Read more.
ALZpath Broadens Strategic Agreement with Alamar Biosciences to Advance Clinical Diagnostics for Alzheimer’s Disease
Expanded collaboration grants Alamar commercial rights to utilize ALZpath’s proprietary pTau217 antibody in blood-based diagnostic tests for clinical use CARLSBAD,... Read more.